Pay in 4 interest-free payments of $5.16 Learn more
Ships within 48 hours · Estimated delivery Aug 10 - Aug 15
A randomized, placebo-controlled Phase 2 trial (NCT02453711) of once-daily subcutaneous semaglutide (0.05, 0.1, 0.2, 0.3, or 0.4 mg following 4-weekly escalations) in subjects with obesity without T2D, showed mean weight losses of -6.0% (0.05 mg) to -13.8% (0.4 mg) with semaglutide vs -2.3% with placebo at week 52
Effects of exercise training on bone health parameters in individuals with obesity: a systematic review and meta-analysis
Find a clinic near your to review your GLP-1 eligibility
Start here: Frequently asked questions How fast will I see weight loss results
Follow the standard titration: Increase by 0.25 mg increments every 4 weeks (0.25 0.5 1.0 1.7 2.4 mg) based on tolerability
Improve blood sugar and insulin levels Originally developed for diabetes, GLP-1s help stabilize energy, curb cravings, and support overall metabolic wellness
US$ 26.59
US$ 24.35
US$ 28.86
US$ 25.00
